ライフサイエンスコーパス: nasogastric tube

1 r 5 days or placebo was administered through nasogastric tube.

2 -sided CDH and 14 with right-sided CDH-had a nasogastric tube.

3 newborns, at the time of routine changing of nasogastric tubes.

4 c gastrostomy tubes compared with those with nasogastric tubes (20.3% vs. 40.7%, respectively; p = .0

5 r more days or the need for reinsertion of a nasogastric tube after starting oral diet in the absence

6 that selective, rather than routine, use of nasogastric tubes after abdominal surgery (2 meta-analys

7 casein and whey protein were collected by a nasogastric tube and protein degradation and peptide rel

8 They are more comfortable than nasogastric tubes and may be kept in place for several m

9 The positions of nasogastric tubes and umbilical venous catheters vary in

10 eadmission, ileus (defined as reinsertion of nasogastric tube), and intra-abdominal infection and ass

11 (two 40-mg doses on day 1, via orogastric or nasogastric tube, and 40 mg each day thereafter) or intr

12 rred during passage of the bougie dilator or nasogastric tube, and two occurred after surgery seconda

13 ered the presence of bright red blood in the nasogastric tube as failure of SUP.

14 ium was administered orally or by means of a nasogastric tube as part of a routine protocol for CT ev

15 need to handle stool" and "receiving FMT by nasogastric tube" as most unappealing.

16 low-fat elemental-like diet administered by nasogastric tube during severe pancreatitis does not wor

17 Any use of oxygen therapy, nasogastric-tube feeding, or ventilatory support was rec

18 ngth of stay, use of oxygen supplementation, nasogastric-tube feeding, ventilatory support, and relat

19 razole suspension was administered through a nasogastric tube, followed by 5 to 10 mL of tap water.

20 used to determine the appropriate length of nasogastric tube for optimal placement in adults.

21 Donor fecal infusion via nasogastric tube, gastroscope or colonoscope in children

22 ted no difference between groups (60% in the nasogastric tube group and 80% in the colonoscopy group;

23 des, fecal infusion either rectally or via a nasogastric tube has become a viable option for the trea

24 All nasogastric tubes in the 14 patients with right-sided CD

25 unrelated donors, comparing colonoscopic and nasogastric tube (NGT) administration.

26 e usage of this equipment in the guidance of nasogastric tube (NGT) insertion.

27 and two or more vomiting episodes per day or nasogastric tube (NGT) who were previously treated with

28 itamin D3 or placebo was given orally or via nasogastric tube once at a dose of 540,000 IU followed b

29 surgery [odds ratio (OR) = 1], presence of a nasogastric tube (OR = 1.6), intraoperative blood transf

30 ical leak, return to the operating room, and nasogastric tube placement (a surrogate for ileus).

31 acute hepatic failure, prolonged duration of nasogastric tube placement, alcoholism, and an increased

32 stics examined included age, sex, concurrent nasogastric tube presence, primary diagnosis, Acute Phys

33 ence in risk of anastomotic leak, pneumonia, nasogastric tube reinsertion, reoperation, readmission,

34 ze outcomes of anastomotic leaks, pneumonia, nasogastric tube reinsertion, reoperation, readmissions,

35 ly mobilization, incentive spirometry, early nasogastric tube removal, alvimopan usage, and judicious

36 A nasogastric tube should only be placed for symptomatic r

37 ed colectomy, treatment with any antibiotic, nasogastric tube suction, advanced age, and prior antibi

38 Subjects were equipped with a double-lumen nasogastric tube that migrated to the proximal jejunum.

39 Converting nasogastric tubes to percutaneous endoscopic gastrostomy

40 In the PEG versus nasogastric tube trial, 321 patients were enrolled by 47

41 in 71 neonates with CDH to determine whether nasogastric tubes, umbilical venous catheters, and umbil

42 Improper placement of nasogastric tube used for feeding may lead to serious co

43 The nasogastric tube was clamped for 1 to 2 hrs after each a

44 In 13 patients, the tip of the nasogastric tube was lodged at the esophagogastric junct

45 rolled trial of its kind, fecal infusion via nasogastric tube was shown to be beneficial in treating

46 e who received enteral nutrition through the nasogastric tube were excluded from enrollment.

47 site, postoperative comorbidity, stoma, and nasogastric tube) with LRD patients having an adjusted 1